Malaysian pharmaceutical industry: Opportunities and challenges

Journal of Generic Medicines

Volumn 6, Issue 3, 2009, Pages 246-252

  Hassali, Mohamed Azmi ^a   Yuen, Kah Hay ^a   Ibrahim, Mohamed Izham Mohamed ^a   Wong, Jia Woei ^b   Ng, Bee Hong ^b   Ho, David Sue San ^b  

^a SCHOOL OF PHARMACEUTICAL SCIENCES   (Malaysia)

^b Hovid Bhd ^*  (Malaysia)

Author keywords

[No Author keywords available]

Indexed keywords

GENERIC DRUG;

BIOEQUIVALENCE; DRUG CONTROL; DRUG COST; DRUG INDUSTRY; DRUG MANUFACTURE; DRUG MARKETING; DRUG QUALITY; ECONOMIC DEVELOPMENT; HEALTH CARE FINANCING; HEALTH CARE SYSTEM; MALAYSIA; PUBLIC HEALTH SERVICE; REVIEW;

EID: 67549132157     PISSN: 17411343     EISSN: 17417090     Source Type: Journal    
DOI: 10.1057/jgm.2009.12     Document Type: Review

References (15)

1. Simoens, S. (2007) International comparison of generic medicine prices. Current Medical Research and Opinion 23(11): 2647-2654.
2. Shafie, A. A. and Hassali, M. A. (2008) Price comparison between innovator and generic medicines sold by community pharmacists in the state of Penang. Journal of Generic Medicines 6(1): 35-42.
3. Ping, C. C., Bahari, M. B. and Hassali, M. A. (2008) A pilot study on generic medicine substitution practices among community pharmacists in the state of Penang, Malaysia. Pharmacoepidemiology and Drug Safety 17(1): 82-89.
4. Department of Statistics. (2007) Malaysia Year Book of Statistics 2007. Kuala Lumpur, Malaysia: Department of Statistics Malaysia.
5. Yu, C. P., Whynes, D. K. and Sach, T. H. (2008) Equity in health care financing: The case of Malaysia. International Journal of Equity Health 9(7): 1-15.
6. Tarn, Y. H. et al (2008) Health-care systems and pharmacoeconomic research in Asia-Pacific region. Value Health 11(1): S137-S155.
7. Lek, C. S. (2005) Health plan to be modelled after Sosco. The Star (Malaysia), http://202.144.202.76/new_mps/cfm/ localnews_view.cfm?id=822, accessed 15 February 2007.
8. Goh, A., Faridah, A., Rosminah, M. D., Nour Hanah, O. and Noor Aini, Z. (2007) Expenditure on Medicines in Malaysia: Estimates from Malaysian Statistics on Medicines 2005. 7th Ministery of Health-Academy of Medicine Malaysia Scientific Meeting.
9. Azmi, I. M. and Alavi, R. (2001) TRIPS, patents, technology transfer, foreign direct investment and the pharmaceutical industry in Malaysia. Journal of World Intellectual Property 4(6): 947-976.
10. IMS. (2006) MGV Report. IMS: Switzerland.
11. Tham, L. H. and Yahya, I. (2008) Malaysian Pharmaceutical Industry Outlook 2008. Frost & Sullivan, http://www.frost.com/prod/servlet/ market-insight-top.pag?docid=126369590, accessed 6 February 2009.
12. Malaysian Organization of Pharmaceutical Industries (MOPI). (1999) The Malaysian Pharmaceutical Industries, http://www.mopi.org.my/home.html, accessed 31 January 2009.
13. MIDA. (2009) Pharmaceuticals industry, http://www.mida.gov.my/en_v2/ index.php?page=pharmaceuticals#expand1,%20accessed%2015% 20February%202009, accessed 9 April 2009.
14. MIDA. (2008) Malaysia's pharmaceutical industry sustains growth, http://www.mida.gov.my/en_v2/index.php?mact= News,cntnt01,detail,0&cntnt01articleid=83&cntnt01returnid=131, accessed 6 February 2009.
15. Nandita, S. and Bharadwaj, K. V. (2007) The generics boom. Biospectrum (May-June): 14-29.